← Back to Search

NutraHeal for Foot Injuries and Disorders

N/A

Waitlist Available

Led By Lenore Moyer, DPM

Research Sponsored by NutraHeal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, the day of surgery, and at 1 and 3 weeks after surgery.

Awards & highlights

Study Summary

This trial will compare the effects of two different nutritional supplements on foot surgery patients.

Eligible Conditions

Foot Injuries and Disorders

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, the day of surgery, and at 1 and 3 weeks after surgery.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, the day of surgery, and at 1 and 3 weeks after surgery.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, the day of surgery, and at 1 and 3 weeks after surgery. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Injury wounds

Secondary outcome measures

Fatigue

Pain Intensity

Pain

+1 more

Other outcome measures

Patient Satisfaction

Physical Function

Sleep Disturbance

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: NutraHeal PlusExperimental Treatment1 Intervention

NutraHeal Plus™ is a nutritional supplement that contains 80 mg of Calcium as Calcium Hydroxymethylbutyrate Monohydrate, 7.5 mg of Zinc, 600 mg of Calcium Hydroxymethylbutyrate Monohydrate, 45 mg of Bromelain, and 7.5 mg of reduced Nicotinamide Adenine Dinucleotide (NADH).

Group II: NutraHealExperimental Treatment1 Intervention

NutraHeal™ is a nutritional supplement that contains 7.5 micrograms (300 IU) of Vitamin D3, 80 mg of Calcium as Calcium Hydroxymethylbutyrate Monohydrate, 7.5 mg of Zinc, 600 mg of Calcium Hydroxymethylbutyrate Monohydrate, and 45 mg of Bromelain.

Group III: Standard of CareActive Control1 Intervention

Receive standard of care for 1 week prior to surgery and 3 weeks after foot surgery.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

NutraHeal Plus

2022

N/A

~50

NutraHeal

2022

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NutraHealLead Sponsor

Lenore Moyer, DPMPrincipal InvestigatorAdvanced Regional Center for Ankle and Foot Care

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are partaking in this experiment?

"Affirmative. Records on clinicaltrials.gov highlight that this medical trial, which was first published on August 29th 2022, is currently enrolling patients. Approximately 45 participants need to be enrolled from 3 different research sites."

Answered by AI

Does this research project accept participants who are 18 or older?

"The parameters for inclusion in this research trial begin at 20 years old and cap out at 80."

Answered by AI

Are there any open spots available for enrollment in this study?

"Affirmative; according to information published on the clinicaltrials.gov website, this scientific experiment is currently searching for volunteers and has been since August 29th 2022. The most recent update was made September 27th of last year and 45 participants are being recruited across 3 different sites."

Answered by AI

For whom is this medical experiment most suitable?

"In this clinical study, 45 individuals with the given condition aged between 20 and 80 will be accepted. Eligibility requires that prospective participants are at least 20 years old and undergoing either a matrixectomy or wart removal procedure on their feet."

Answered by AI

Recent research and studies

Cell MetabolismJournal

NAD+ in Brain Aging and Neurodegenerative Disorders

Lautrup, Sofie, David A. Sinclair, Mark P. Mattson, and Evandro F. Fang. 2019. “NAD+ in Brain Aging and Neurodegenerative Disorders”. Cell Metabolism. Elsevier BV. doi:10.1016/j.cmet.2019.09.001.

Patient Safety in SurgeryJournal

Vitamin D Status and Surgical Outcomes: A Systematic Review

Iglar, Paul J, and Kirk J Hogan. 2015. “Vitamin D Status and Surgical Outcomes: A Systematic Review”. Patient Safety in Surgery. Springer Science and Business Media LLC. doi:10.1186/s13037-015-0060-y.

Autoimmunity ReviewsJournal

Zinc and Its Role in Immunity and Inflammation

Bonaventura, Paola, Giulia Benedetti, Francis Albarède, and Pierre Miossec. 2015. “Zinc and Its Role in Immunity and Inflammation”. Autoimmunity Reviews. Elsevier BV. doi:10.1016/j.autrev.2014.11.008.

NutrientsJournal